6th Biobased Chemicals 2015 아젠다


첫째날 둘째날
첫째날 - 2015년 11월 16일(월)
7:00 등록 및 아침식사
7:55 환영 및 개회사

환영 및 개회사
8:00


TBD
지속 가능한 생화학적 생산의 신규 기술과 플랫폼
.
Moderator: William Radany ,Verdezyne
8:45




Walter Rakitsky
Senior Vice President, Emerging Business
Solazyme
9:10


Michele Rubino
Chief Operating Officer
Beta Renewables
9:35


Gary Diamond
Vice President, Product Development
Rennovia
10:00 휴식시간
10:45 바이오매스 에너지 변환을 위한 C5 화학 플랫폼



Olga Selifonova
Founder & CEO
Reluceo Holdings LLC
Sustainable future of humanity beyond the age of fossil carbon depends on the use of non-food agricultural biomass as the principal source of valuable “carbon ore”. C5 carbohydrates are the most accessible and the most undervalued major parts of non-food cellulosic biomass from agriculture and managed forestry. Our technology enables selective isolation and utilization of C5 carbohydrates (hemicelluloses) and opens up new economics for conversion of biomass to benign-by-design sustainable industrial products. Our product pipeline caters to markets for impactful industrial materials such as performance bioplastics, special function polymers, and for functional health food ingredients useful for prevention and management of the global pandemics of diabetes affecting nearly 400 million people. Our process is devoid of economic risks associated with technologies for separation of cellulose from lignin. The process co-generates captive energy along with some useful amount of ethanol for self-sufficiency of our operations. The simplicity of our C5-centered hydrolysis process and the use of optimally-sized equipment permit a fractal consolidation approach for biomass processing and downstream steps, thereby enabling (i) dramatic reduction of biomass transportation costs from the point of origin to the point of primary processing and (ii) staggered deployment of CapEx for ramping-up production according to supply and demand. Our technology and product pipeline carry the potential to double economic output and earnings of existing agriculture through smarter use of biomass without calling for planting new land or increasing crop yields, thereby enabling a non-incremental step toward sustainability of the world economy.
11:10


David Sudolsky
President & CEO
Anellotech
11:35 이산화탄소로부터 화학물질을 생산하기 위한 지속 가능한 플랫폼





Sissi Liu
Director, Business Development
JOULE
This presentation will address the progress and potential of a solar-driven platform for the conversion of industrial waste CO2 into chemicals of interest. Unlike processes dependent on agricultural or algal biomass, this process depends only on the availability of sunlight, waste CO2, non-potable water and non-arable land. The platform applies engineered catalysts (cyanobacteria) to directly produce and secrete the molecules of interest as a product of photosynthetic metabolism, with no further processing required. Proof of concept has already been achieved for a number of high-value chemicals, and the platform is currently operating at demonstration scale with the production of ethanol.

Benefits:
• Co-opting photosynthesis for industrial gain
• Progress from lab to field demonstration
• Global applicability
• Beneficial impact of upcycling waste CO2
12:00 설탕을 원료로 한 저비용 바이오 모노머 생산을 위한 촉매 기술



Kresten Egeblad
Business Development Manager
Haldor Topsøe A/S
Haldor Topsoe has developed innovative catalytic technologies for the polymer and resin industries in order to accommodate for the market pull for bio-based replacements of existing products. The new and proprietary technologies allows for production of bio-based glycols and lactate esters from different types of bio feedstock. The key features of these technologies are:
1. Flexibility: can take in first and second generation carbohydrate feedstock (C6, C5),
2. Efficiency: 70% carbon yield from sugar feedstock with high selectivity towards the desired product,
3. Profitable: Enable cost-competitive production from biomass without relying on a green premium
4. Speed: continuous catalytic process yields products in less time compared to fermentation.
At present, demonstration and commercialisation partnerships are being established in order to commercialise Topsoe's new bio process.

Key benefits:
- Further valorization of sugar streams into bio-chemicals
- Cost competitive production of bio glycols and bio monomers
- High selectivity to the desired products from a variety of feedstock
- Fast, continuous processes
12:25 점심식사
1:55




John Bissell
Co-Founder, Chief Executive Officer
Micromidas
바이오케미컬의 상품화를 위한 유리한 원료.
.

Moderator: Gert-Jan Gruter, Avantium
2:20 DDDA의 상품화를 위한 원료 플렉서블 어프로치



William Radany
President and Chief Executive Officer
Verdezyne
Verdezyne has developed a proprietary platform for engineering yeast to metabolize multiple non-food-based renewable feedstocks to produce a number of widely used, high-value chemicals including adipic acid, sebacic acid and dodecanedioic acid (DDDA). Verdezyne has optimized its yeast strains to produce maximum yields of the targeted products with minimal unwanted byproducts. The technology is feedstock flexible, allowing the ability to shift among materials that are in the least demand and lowest cost. The company's intellectual property platform has been developed to create a springboard from which to launch multiple products with minimal development time. Verdezyne has developed and scaled its technology from proof of concept to commercialization stage, and has announced its plan to build and operate the world's first plant for the large-scale production of bio-based DDDA.
2:45


Josh Silverman
Chief Scientific Officer & Co-Founder
Calysta Energy
3:10 휴식시간
3:55


Sean Simpson
Chief Scientific Officer & Co-Founder
LanzaTech
4:20

Anna Rath
President & Chief Executivs Officer
NexSteppe
4:45

Gert-Jan Gruter

Chief Technology Officer
Avantium
5:10 제출된 모범적 초록 기반 구두 프레젠테이션
To be considered for an oral presentation, please submit an abstract here by October 16, 2015. Selected presentations will be based on quality of abstract and availability. Presentation slots fill up fast so please submit your abstract ASAP.
5:40 리셉션 및 포스터 세션
첫째날 둘째날
둘째날 - 2015년 11월 17일(화)
7:30 아침식사
전략적 파트너십

특별 강연
8:00

Simon Herriott
Global Business Director, Biomaterials
DuPont Industrial Biosciences
8:25

William Baum
Biobased Chemical Consultant
Genomatica
8:50

Abe Hughes
Senior Vice President of Business Development
POET
9:15




Cora Leibig
Vice President, R&D
Segetis
바이오케미컬을 위한 효과적 상품화
.
Moderator: William Baum . Genomatica
9:40 Cargill의 CB1 플랫폼을 이용한 바이오케미컬의 효과적 상품화





Pirkko Suominen
Corporate Fellow; Assistant Vice President, Director, Biotechnology R&D
Cargill
Advances in metabolic engineering have impacted fermentation industry and today very large scale industrial fermentation processes utilize metabolically engineered microbes. One early example was Cargill's yeast based low pH lactic acid process, which was implemented in 2008 and completely displaced the conventional bacterial process at Cargill Blair plant. Predicted costs savings over the traditional process were realized during the first year of operation and further strain and process development has led to continuous cost reduction, and improved environmental foot print.

Cargill's CB1 yeast platform has many characteristics required in cost effective, robust industrial fermentation processes. These include high yield and productivity, tolerance to low pH, ethanol, high temperature and common inhibitors in cellulosic hydrolysates. These properties make it a good choice as a biocatalyst for many biobased chemicals, including cellulosic ethanol. Cargill's BioRD team has developed CB1 to efficiently ferment both C5 and C6 sugars in cellulosic hydrolysates. Pathways for different chemicals can now be engineered into CB1 platform strains for chemical production from either traditional C6 sugars or from cellulosic derived C5 and C6 sugars. Examples of using the CB1 platform for industrial products will be given.
10:05 휴식시간
10:35 왜 자동화인가? 재생 제품에 대한 Amyris 플랫폼 어프로치





Joel Cherry
President, R&D
Amyris
Amyris is a synthetic biology company dedicated to providing high-performance alternatives to petroleum-sourced fuels, chemicals, and consumer goods. We have created a world-class synthetic biology platform that applies the principles of engineering to biology, pulling together scientists with skills in automation, computing and biology to create an assembly line for genetically manipulating organisms, testing those organisms for production of the desired compound, and iteratively learning from this design-build-test cycle. This allows us to continuously improve our designs, reducing both the time and cost to go from concept to commercial viability with new molecule production. The result of this approach has been the creation of organisms that can produce precursors to an anti-malarial drug, diesel and jet fuels, a cosmetic emollient, and multiple fragrance compounds, each reaching commercial-level production faster than the last.

Amyris's current business centers on fermentation of sugars by yeast to produce a class of hydrocarbons known as isoprenoids. In this presentation I will describe Amyris's progress towards the economical production of multiple isoprenoid products and the importance of automation to reducing time-to-market.
11:00




Patrick Gruber
Chief Executive Officer
Gevo
최종사용자의 응용과 소비자 제품
11:25




Steven Cohen
Director, Catalyst and Chemicals Technology
Elevance Renewable Sciences
11:50




Martin Mitchell
Business Development Manager
Clariant
12:15




TBD
12:40 점심식사(GTCbio 제공)
2:00 컨퍼런스 폐막
첫째날 둘째날


* 주최측 사정에 따라 사전 예고없이 프로그램이 변경될 수 있습니다.